Results 271 to 280 of about 32,100 (296)

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

Annals of Oncology, 2003
Zelek Laurent, MIGUEL Martin, M Namer
exaly  

Anthracycline derivatives

2005
EDWARDS KATARIN, SJOEBERG STEFAN, CARLSSON JOERGEN, GEDDA LARS   +3 more
openaire   +4 more sources

Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy

Cancer Letters, 2015
Pin Wu, Zhigang Zhang
exaly  

Cardiac Safety of Liposomal Anthracyclines

Oncologist, 2003
Tamar Safra
exaly  

Anthracyclines - Pharmacology and Resistance, A Review

Current Pharmaceutical Design, 1995
H J M Groen, W T A Van Der Graaf, E G E De Vries   +2 more
exaly  

Interstrand DNA crosslinking induced by anthracyclines in tumour cells

Biochemical Pharmacology, 1994
Andrzej Skladanowski, Jerzy Konopa, J Konopa   +2 more
exaly  

Ring-B Modified Anthracyclines

Current Pharmaceutical Design, 1999
Francesco Angelucci, Cristina Geroni
exaly  

Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines

Journal of Drug Targeting, 1996
Alberto Gabizon, D Goren
exaly  

CE‐LIF method for the separation of anthracyclines: Application to protein binding analysis in plasma using ultrafiltration

Journal of Separation Science, 2008
Robert O'Connor
exaly  

Anthracyclines

2011
  +4 more sources